Form 4: CVS Executive Sells Shares for Tax Obligations

CVS Health Corp's EVP, Chief Experience & Technology Officer, Tilak Mandadi, disposed of 6,575 shares to cover tax withholding on a restricted stock unit award.

Summary

• Tilak Mandadi, Executive Vice President, Chief Experience & Technology Officer of CVS Health Corp, reported a transaction involving company common stock.
• On November 30, 2025, Mandadi disposed of 6,575 shares of CVS common stock.
• The shares were surrendered at a price of $80.36 per share.
• This transaction was for the payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
• Following this transaction, Mandadi beneficially owns 74,085 shares of CVS common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary event for tax withholding related to executive compensation, carrying a neutral sentiment for the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, which is common across all industries for executives receiving equity awards. It does not reflect broader industry trends or competitive positioning.

Comparison to Industry Standards

• The disposal of shares to cover tax withholding upon the vesting of restricted stock units is a standard practice for executives receiving equity-based compensation across publicly traded companies, including those in the healthcare and retail pharmacy sectors.
• Many companies, similar to CVS Health, facilitate such transactions to manage the tax implications for their executives, often through pre-arranged Rule 10b5-1 plans to ensure compliance and avoid accusations of trading on inside information.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in management's confidence or company fundamentals.
• Employees: No direct impact beyond the executive involved.

Key Dates

Keywords

CVS Health, CVS, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Withholding, Executive Compensation, Tilak Mandadi